Tacrolimus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Prognostic Model of TAC in the Treatment of MN
Condition:   Idiopathic Membranous Nephropathy Intervention:   Drug: Tacrolimus Sponsor:   Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials

Prognostic Model of GC/TAC in the Treatment of MN
Condition:   Idiopathic Membranous Nephropathy Intervention:   Drug: glucocorticoid + tacrolimus Sponsor:   Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials

Prognostic Model of TAC in the Treatment of MN
Condition:   Idiopathic Membranous Nephropathy Intervention:   Drug: Tacrolimus Sponsor:   Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials

Prognostic Model of GC/TAC in the Treatment of MN
Condition:   Idiopathic Membranous Nephropathy Intervention:   Drug: glucocorticoid + tacrolimus Sponsor:   Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials

Prognostic Model of TAC in the Treatment of MN
Condition:   Idiopathic Membranous Nephropathy Intervention:   Drug: Tacrolimus Sponsor:   Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials

Prognostic Model of GC/TAC in the Treatment of MN
Condition:   Idiopathic Membranous Nephropathy Intervention:   Drug: glucocorticoid + tacrolimus Sponsor:   Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials

Prognostic Model of TAC in the Treatment of MN
Condition:   Idiopathic Membranous Nephropathy Intervention:   Drug: Tacrolimus Sponsor:   Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials

Prognostic Model of GC/TAC in the Treatment of MN
Condition:   Idiopathic Membranous Nephropathy Intervention:   Drug: glucocorticoid + tacrolimus Sponsor:   Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials

Prognostic Model of TAC in the Treatment of MN
Condition:   Idiopathic Membranous Nephropathy Intervention:   Drug: Tacrolimus Sponsor:   Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials

Prognostic Model of GC/TAC in the Treatment of MN
Condition:   Idiopathic Membranous Nephropathy Intervention:   Drug: glucocorticoid + tacrolimus Sponsor:   Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials

Prognostic Model of TAC in the Treatment of MN
Condition:   Idiopathic Membranous Nephropathy Intervention:   Drug: Tacrolimus Sponsor:   Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials

Prognostic Model of GC/TAC in the Treatment of MN
Condition:   Idiopathic Membranous Nephropathy Intervention:   Drug: glucocorticoid + tacrolimus Sponsor:   Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials